Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006;8(4):215.
doi: 10.1186/ar1977.

Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data

Christina D Chambers  1 , Zuhre N Tutuncu, Diana Johnson, Kenneth L Jones
Affiliations
Review

Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data

Christina D Chambers et al. Arthritis Res Ther. 2006.

Abstract

For female patients with rheumatoid arthritis, the availability of a host of new disease modifying antirheumatic drugs has raised important questions about fetal safety if a woman becomes pregnant while she is being treated. In addition, there is limited safety information regarding many of the older medications commonly used to treat rheumatoid arthritis in women of reproductive age. Current summary pregnancy risk information for selected medications used to treat rheumatoid arthritis is reviewed in the context of the pregnancy label category. In addition, the strengths and weaknesses of post-marketing strategies for developing new pregnancy safety information are described.

PubMed Disclaimer

References

    1. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998;30:24–29. doi: 10.2307/2991522. - DOI - PubMed
    1. Floyd RL, Dencoufle P, Hungerford DW. Alcohol use prior to pregnancy recognition. Am J Prev Med. 1999;17:101–107. doi: 10.1016/S0749-3797(99)00059-8. - DOI - PubMed
    1. Scialli AR, Buelke-Sam JL, Chambers CD, Friedman JM, Kimmel CA, Polifka JE, Tassinari MS. Communicating risks during pregnancy: A workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs. Birth Defects Res A Clin Mol Teratol. 2004;70:7–12. doi: 10.1002/bdra.10150. - DOI - PubMed
    1. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol. 2002;100:465–473. doi: 10.1016/S0029-7844(02)02122-1. - DOI - PubMed
    1. Teo SK, Denny FH, Stirling DI, Thomas SD, Morseth S, Hoberman AM. Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand White rabbits. Birth Defects Res B. 2004;71:1–16. doi: 10.1002/bdrb.10054. - DOI - PubMed

MeSH terms

Substances